Couples who were found to be genetic carriers for autosomal recessive or X-linked genetic conditions often opted to change their reproductive strategy, a large Australian population-based study found.

It can be argued that the devastation of a cancer diagnosis is rooted as much in the prospect of treatment as it is in the prospect of death. In particular, drugs used to treat cancer can cause severe ...

Myriad Genetics, Inc. announced a study indicating that the use of its online screening tool, MyGeneHistory®, alongside a virtual education program, significantly increased the completion rates for ...

Genomic sequencing technology allows for identification of reproductive couples with an increased chance, as compared with that in the general population, of having a child with an autosomal recessive ...

Are you ready for the era of designer babies? Advances in gene sequencing have now made it possible for embryos to be screened for a host of genetic diseases and physical traits. Private companies are ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Are you ready for the era of designer babies? Advances in gene sequencing have now made it possible for embryos to be screened for a host of genetic diseases and physical traits. Private companies are ...

SALT LAKE CITY, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that the Prequel® Prenatal Screen is now available ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a ...